COVID‐19 pneumonia in kidney transplant recipients—Where we are?

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Identification of Kidney Transplant Recipients with Coronavirus Disease 2019

(2020) Hui Zhang et al.   EUROPEAN UROLOGY

A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia

(2020) Federico Alberici et al.   KIDNEY INTERNATIONAL

A Test in Context: D-Dimer

(2017) Jeffrey I. Weitz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus

(2016) Jean-François Rossignol   Journal of Infection and Public Health

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506

(2012) Javier Carbajo-Lozoya et al.   VIRUS RESEARCH

Hydroxychloroquine: From Malaria to Autoimmunity

(2011) Ilan Ben-Zvi et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY